Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports.

作者: Jose de Leon , D. Michele Nikoloff

DOI: 10.1017/S109285290001628X

关键词: HypnoticUltrarapid metabolizerAnesthesiaMedicineDiphenhydraminePopulationHealthy subjectsPharmacologyCYP2D6

摘要: Diphenhydramine is a widely used antihistaminic that frequently included in over-the-counter medications. Due to its sedating properties, diphenhydramine some hypnotic preparations. Occasionally, patients respond with paradoxical excitation. There are no studies on the prevalence of excitation healthy subjects. appears cause mild inhibition cytochrome P450 (CYP) 2D6 enzyme. This can be interpreted as competitive inhibition, suggesting may CYP2D6 substrate. When subjects have at least three active copies gene, they called ultrarapid metabolizers (UMs) and present high metabolic capacity for substrates. In United States, UMs account approximately 1% 2% population. We describe who reported diphenhydramine. These cases suggest UMs, converted compound causes due abnormally activity. Therefore, such individuals higher risk Although these only anecdotal from reports illustrate need larger, more formal responses metabolism.

参考文章(18)
M Ingelman-Sundberg, L Bertilsson, I Johansson, I Persson, F Rodrigues, E Aklillu, Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 441- 446 ,(1996)
M Ingelman-Sundberg, F Sjöqvist, L Bertilsson, I Johansson, M L Dahl, Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. Journal of Pharmacology and Experimental Therapeutics. ,vol. 274, pp. 516- 520 ,(1995)
Maria Johnson, Courtney Markham-Abedi, Margaret T. Susce, Elaina Murray-Carmichael, Stuart McCollum, Jose de Leon, A poor metabolizer for cytochromes P450 2D6 and 2C19: a case report on antidepressant treatment. Cns Spectrums. ,vol. 11, pp. 757- 760 ,(2006) , 10.1017/S1092852900014887
Jose de Leon, Lori Dinsmore, Peter Wedlund, Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. Journal of Clinical Psychopharmacology. ,vol. 23, pp. 420- 421 ,(2003) , 10.1097/01.JCP.0000085421.74359.60
I. Johansson, E. Lundqvist, L. Bertilsson, M. L. Dahl, F. Sjoqvist, M. Ingelman-Sundberg, Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 11825- 11829 ,(1993) , 10.1073/PNAS.90.24.11825
Bettina A Hamelin, Asmàa Bouayad, Julie Méthot, Jean Jobin, Pierre Desgagnés, Paul Poirier, Joakim Allaire, Jean Dumesnil, Jacques Turgeon, Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clinical Pharmacology & Therapeutics. ,vol. 67, pp. 466- 477 ,(2000) , 10.1067/MCP.2000.106464
Jose de Leon, AmpliChip CYP450 test: personalized medicine has arrived in psychiatry. Expert Review of Molecular Diagnostics. ,vol. 6, pp. 277- 286 ,(2006) , 10.1586/14737159.6.3.277
Jose de Leon, Margaret T. Susce, Run-Mei Pan, Maureen Fairchild, Walter H. Koch, Peter J. Wedlund, The CYP2D6 Poor Metabolizer Phenotype May Be Associated With Risperidone Adverse Drug Reactions and Discontinuation The Journal of Clinical Psychiatry. ,vol. 66, pp. 15- 27 ,(2005) , 10.4088/JCP.V66N0103
Margaret T. Susce, Elaina Murray-Carmichael, Jose de Leon, Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 30, pp. 1356- 1358 ,(2006) , 10.1016/J.PNPBP.2006.03.018
Roman A. McLellan, Mikael Oscarson, Janeric Seidega??rd, David A. Price Evans, Magnus Ingelman-Sundberg, Frequent Occurrence of CYP2D6 Gene Duplication in Saudi Arabians Pharmacogenetics. ,vol. 7, pp. 187- 191 ,(1997) , 10.1097/00008571-199706000-00003